Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ORCHID PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    ORCHID PHARMA
Mar-23
ADCOCK INGRAM
Jun-14
ORCHID PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs439319-   
Low Rs273230-   
Sales per share (Unadj.) Rs163.194.9-  
Earnings per share (Unadj.) Rs13.5-23.9-  
Cash flow per share (Unadj.) Rs27.0-19.8-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs168.774.5-  
Shares outstanding (eoy) m40.82168.78-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.22.9 75.4%   
Avg P/E ratio x26.3-11.5 -228.9%  
P/CF ratio (eoy) x13.2-13.9 -95.3%  
Price / Book Value ratio x2.13.7 57.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m14,52246,340 31.3%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m6542,908 22.5%   
Avg. sales/employee Rs Th03,730.7-  
Avg. wages/employee Rs Th0677.5-  
Avg. net profit/employee Rs Th0-940.1-  
INCOME DATA
Net Sales Rs m6,65916,016 41.6%  
Other income Rs m194112 173.2%   
Total revenues Rs m6,85316,128 42.5%   
Gross profit Rs m1,235-2,775 -44.5%  
Depreciation Rs m548691 79.3%   
Interest Rs m329434 75.8%   
Profit before tax Rs m552-3,788 -14.6%   
Minority Interest Rs m0-11 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m0237 0.0%   
Profit after tax Rs m552-4,036 -13.7%  
Gross profit margin %18.5-17.3 -107.0%  
Effective tax rate %0-6.2 -0.0%   
Net profit margin %8.3-25.2 -32.9%  
BALANCE SHEET DATA
Current assets Rs m5,01011,730 42.7%   
Current liabilities Rs m3,7196,600 56.3%   
Net working cap to sales %19.432.0 60.5%  
Current ratio x1.31.8 75.8%  
Inventory Days Days57111 51.7%  
Debtors Days Days1,180124 951.7%  
Net fixed assets Rs m7,2426,838 105.9%   
Share capital Rs m40874 548.9%   
"Free" reserves Rs m6,4780-   
Net worth Rs m6,88612,571 54.8%   
Long term debt Rs m1,4884,418 33.7%   
Total assets Rs m12,25223,747 51.6%  
Interest coverage x2.7-7.7 -34.6%   
Debt to equity ratio x0.20.4 61.5%  
Sales to assets ratio x0.50.7 80.6%   
Return on assets %7.2-15.2 -47.4%  
Return on equity %8.0-32.1 -25.0%  
Return on capital %10.5-19.8 -53.1%  
Exports to sales %81.90-   
Imports to sales %37.60-   
Net fx Rs m2,7260-   
CASH FLOW
From Operations Rs m1831,367 13.4%  
From Investments Rs m-312-420 74.4%  
From Financial Activity Rs m3124,009 7.8%  
Net Cashflow Rs m1834,957 3.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.4 Rs / ZAR

Compare ORCHID PHARMA With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare ORCHID PHARMA With: AAREY DRUGS  VIMTA LABS  SAROJA PHARMA INDUSTRIES INDIA LTD.  ADESHWAR MEDITEX  CIPLA  



Today's Market

Sensex Today Falls 1,000 Points from Day's High, Slides for 4th Day | Nifty Below 22,100 | Infosys, Bajaj Auto Surge Ahead of Q3 Results Sensex Today Falls 1,000 Points from Day's High, Slides for 4th Day | Nifty Below 22,100 | Infosys, Bajaj Auto Surge Ahead of Q3 Results(Closing)

It was indeed a volatile trading session for Indian share markets today. Benchmark indices swung between gains and losses throughout the day.